M. Rother

4.8k total citations · 1 hit paper
8 papers, 1.4k citations indexed

About

M. Rother is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, M. Rother has authored 8 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Pathology and Forensic Medicine. Recurrent topics in M. Rother's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (3 papers) and Genetic factors in colorectal cancer (2 papers). M. Rother is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (3 papers) and Genetic factors in colorectal cancer (2 papers). M. Rother collaborates with scholars based in Canada, Spain and Germany. M. Rother's co-authors include Jean‐Yves Douillard, Jennifer Gansert, Paul Ruff, David Cunningham, Salvatore Siena, Josep Tabernero, Ronald L. Burkes, Jean‐Luc Canon, Michael Wolf and Mario Barugel and has published in prestigious journals such as Journal of Clinical Oncology, Cellular and Molecular Life Sciences and Clinical Colorectal Cancer.

In The Last Decade

M. Rother

8 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study

2010 1.4k citations Jean‐Yves Douillard, Salvatore Siena et al. Journal of Clinical Oncology profile →

Peers

M. Rother

ONCOL

PRM

HEPAT

PFM

SURGE

Yevhen Hotko Ukraine

Eugenio Marcuello Spain

Ilona Kocáková Czechia

Yousif Abubakr United States

José María Viéitez Spain

Belguendouz Bendahmane France

M. E. Vega-Villegas Spain

Joe McKendrick Australia

Jean‐Luc Canon Belgium

M. Elisa Vink-Börger Netherlands

Yevhen Hotko Ukraine

M. Rother

1.2k ×1.0

ONCOL

609 ×1.1

PRM

279 ×0.8

HEPAT

315 ×0.9

PFM

208 ×0.8

SURGE

Citations per year, relative to M. Rother M. Rother (= 1×) peers Yevhen Hotko

Countries citing papers authored by M. Rother

Since Specialization

Citations

This map shows the geographic impact of M. Rother's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rother with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rother more than expected).

Fields of papers citing papers by M. Rother

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Rother. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rother. The network helps show where M. Rother may publish in the future.

Co-authorship network of co-authors of M. Rother

This figure shows the co-authorship network connecting the top 25 collaborators of M. Rother. A scholar is included among the top collaborators of M. Rother based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Rother. M. Rother is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Asmis, Timothy R., Scott Berry, Roxanne Cosby, et al.. (2014). Strategies of Sequential Therapies in Unresectable Metastatic Colorectal Cancer: A Meta-Analysis. Current Oncology. 21(6). 318–328. 12 indexed citations

2.

Douillard, Jean‐Yves, Salvatore Siena, Josep Tabernero, et al.. (2013). Overall survival (OS) analysis from PRIME: Randomized phase III study of panitumumab (pmab) with FOLFOX4 for first-line metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 31(15_suppl). 3620–3620. 10 indexed citations

3.

Rother, M., et al.. (2013). Time to adjuvant chemotherapy (AC) in stage III colon cancer at a community cancer center: A quality improvement initiative.. Journal of Clinical Oncology. 31(15_suppl). e17503–e17503. 1 indexed citations

4.

Douillard, Jean‐Yves, Salvatore Siena, James T. Cassidy, et al.. (2010). Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study. Journal of Clinical Oncology. 28(31). 4697–4705. 1351 indexed citations breakdown →

5.

Siena, Salvatore, Josep Tabernero, David Cunningham, et al.. (2010). Randomized phase III study of panitumumab (pmab) with FOLFOX4 compared to FOLFOX4 alone as first-line treatment (tx) for metastatic colorectal cancer (mCRC): PRIME trial analysis by epidermal growth factor receptor (EGFR) tumor staining.. Journal of Clinical Oncology. 28(15_suppl). 3566–3566. 20 indexed citations

6.

Cheung, Winson Y., Gregory R. Pond, M. Rother, et al.. (2008). Adherence to Surveillance Guidelines After Curative Resection for Stage II/III Colorectal Cancer. Clinical Colorectal Cancer. 7(3). 191–196. 24 indexed citations

7.

Kröger, H., et al.. (1967). The effect of antiserum on the metastasis of ascites cells as a function of time. European Journal of Cancer (1965). 3(2). 165–166. 3 indexed citations

8.

Kröger, H., et al.. (1966). The influence of antiserum on the metastasis of ascites cells from the Yoshida Sarcoma. Cellular and Molecular Life Sciences. 22(5). 300–301. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact